title: Adenylyl Cyclase 9 Polymorphisms Reveal Potential Link to HDL Function and Cardiovascular Events in Multiple Pathologies: Potential Implications in Sickle Cell Disease.
abstract: Adenylyl cyclase 9 (ADCY9) mediates β2-adrenoceptor (β2-AR) signalling. Both proteins are associated with caveolae, specialized cholesterol-rich membrane substructures. Apolipoprotein A1 (ApoA1), the major protein component of high-density lipoprotein (HDL), removes cholesterol from cell membrane and caveolae and may thereby influence β2-AR signalling, shown in vitro to be modulated by cholesterol. Patients with Sickle Cell Disease (SCD) typically have low HDL and ApoA1 levels. In patients, mainly of African origin, with SCD, β2-AR activation may trigger adhesion of red blood cells to endothelial cells, leading to vascular occlusive events. Moreover, ADCY9 polymorphism is associated with risk of stroke in SCD. In recent clinical trials, ADCY9 polymorphism was found to be a discriminant factor associated with the risk of cardiovascular (CV) events in Caucasian patients treated with the HDL-raising compound dalcetrapib. We hypothesize that these seemingly disparate observations share a common mechanism related to interaction of HDL/ApoA1 and ADCY9 on β2-AR signalling. This review also raises the importance of characterizing polymorphisms that determine the response to HDL-raising and -mimicking agents in the non-Caucasian population at high risk of CV diseases and suffering from SCD. This may facilitate personalized CV treatments.
authors.affiliation: F.Hoffmann-La Roche Ltd, Basel, Switzerland. eric.niesor@bluewin.ch.|Pre-β1 Consulting, 13c Chemin de Bonmont, 1260, Nyon, Switzerland. eric.niesor@bluewin.ch.
authors.forename: Eric J
authors.initials: EJ
authors.lastname: Niesor
authors.affiliation: F.Hoffmann-La Roche Ltd, Basel, Switzerland.|Cerenis Therapeutics Holding, Labège, France.
authors.forename: Renée
authors.initials: R
authors.lastname: Benghozi
authors.affiliation: University Hospital of Lille, Lille, France.
authors.forename: Philippe
authors.initials: P
authors.lastname: Amouyel
authors.affiliation: Tulane University School of Medicine, New Orleans, USA.
authors.forename: Keith C
authors.initials: KC
authors.lastname: Ferdinand
authors.affiliation: Denver Veterans Affairs Medical Center, Denver, USA.
authors.forename: Gregory G
authors.initials: GG
authors.lastname: Schwartz
keywords: Adenylyl cyclase 9; Apolipoprotein A1; High-density lipoprotein; Malaria; Sickle cell disease; β2-adrenergic receptor